{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T06:14:21Z","timestamp":1668838461800},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1093\/jac\/dkt173","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T00:36:22Z","timestamp":1368837382000},"page":"2205-2209","source":"Crossref","is-referenced-by-count":8,"title":["Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir\/ritonavir-containing regimen"],"prefix":"10.1093","volume":"68","author":[{"given":"Claudia","family":"Alteri","sequence":"first","affiliation":[]},{"given":"Anna","family":"Artese","sequence":"additional","affiliation":[]},{"given":"Gertjan","family":"Beheydt","sequence":"additional","affiliation":[]},{"given":"Maria Mercedes","family":"Santoro","sequence":"additional","affiliation":[]},{"given":"Giosu\u00e8","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Lucia","family":"Parrotta","sequence":"additional","affiliation":[]},{"given":"Ada","family":"Bertoli","sequence":"additional","affiliation":[]},{"given":"Caterina","family":"Gori","sequence":"additional","affiliation":[]},{"given":"Nicoletta","family":"Orchi","sequence":"additional","affiliation":[]},{"given":"Enrico","family":"Girardi","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[]},{"given":"Stefano","family":"Alcaro","sequence":"additional","affiliation":[]},{"given":"Antonella","family":"d'Arminio Monforte","sequence":"additional","affiliation":[]},{"given":"Kristof","family":"Theys","sequence":"additional","affiliation":[]},{"given":"Anne-Mieke","family":"Vandamme","sequence":"additional","affiliation":[]},{"given":"Francesca","family":"Ceccherini-Silberstein","sequence":"additional","affiliation":[]},{"given":"Valentina","family":"Svicher","sequence":"additional","affiliation":[]},{"given":"Carlo Federico","family":"Perno","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"key\n\t\t\t\t20170511114524_DKT173C1","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1128\/JVI.78.19.10501-10506.2004","article-title":"Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus type 1","volume":"78","author":"Travers","year":"2004","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170511114524_DKT173C2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/viro.1999.9720","article-title":"High diversity of HIV-1 subtype F strains in Central Africa","volume":"259","author":"Triques","year":"1999","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170511114524_DKT173C3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.meegid.2007.05.005","article-title":"Increasing genetic distance to HIV-1 subtype B and F1 consensus sequences in the Brazilian epidemic: a challenge for vaccine strategies based on central immunogens?","volume":"7","author":"Bello","year":"2007","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20170511114524_DKT173C4","article-title":"Los Alamos National Laboratory Database"},{"key":"key\n\t\t\t\t20170511114524_DKT173C5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance","volume":"350","author":"Clavel","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511114524_DKT173C6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/apc.2007.0099","article-title":"Protease inhibitor resistance update: where are we now?","volume":"22","author":"Kim","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"key\n\t\t\t\t20170511114524_DKT173C7","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/01.aids.0000131394.76221.02","article-title":"Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure","volume":"18","author":"Ceccherini-Silberstein","year":"2004","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170511114524_DKT173C8","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170511114524_DKT173C9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1742-4690-9-81","article-title":"Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients","volume":"9","author":"Theys","year":"2012","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20170511114524_DKT173C10","first-page":"4","article-title":"Update of the drug resistance mutations in HIV-1: 2011","volume":"19","author":"Johnson","year":"2011","journal-title":"Top HIV Med"},{"key":"key\n\t\t\t\t20170511114524_DKT173C11","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1074\/jbc.M708506200","article-title":"Effect of the active-site D25N mutation on the structure, stability and ligand binding of the mature HIV-1 protease","volume":"283","author":"Sayer","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511114524_DKT173C12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/323604","article-title":"Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy","volume":"184","author":"Perno","year":"2001","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170511114524_DKT173C13","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1086\/386307","article-title":"Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed","volume":"189","author":"Perno","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170511114524_DKT173C14","doi-asserted-by":"crossref","first-page":"e37983","DOI":"10.1371\/journal.pone.0037983","article-title":"Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients","volume":"7","author":"Scherrer","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170511114524_DKT173C15","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1128\/AAC.49.5.2015-2025.2005","article-title":"Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors","volume":"49","author":"Svicher","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114524_DKT173C16","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1128\/JVI.75.16.7462-7469.2001","article-title":"Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients","volume":"75","author":"Kempf","year":"2001","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170511114524_DKT173C17","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1128\/AAC.48.12.4687-4692.2004","article-title":"Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type-1 protease inhibitor-experienced patients","volume":"48","author":"Marcelin","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114524_DKT173C18","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1128\/AAC.46.9.2926-2932.2002","article-title":"Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients","volume":"46","author":"Masquelier","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114524_DKT173C19","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1073\/pnas.251265598","article-title":"Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance","volume":"98","author":"Wang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170511114524_DKT173C20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/aid.2010.0072","article-title":"The HIV type 1 protease L10I minor mutation decreases replication capacity and confers resistance to protease inhibitors","volume":"27","author":"Flor-Parra","year":"2011","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/68\/10\/2205\/16862626\/dkt173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T03:20:09Z","timestamp":1503458409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkt173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,5,17]]},"published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkt173","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}